Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Язвенный колит. К 180-летию описания Карлом Рокитанским
Князев О.В., Каграманова А.В., Парфенов А.И. Язвенный колит. К 180-летию описания Карлом Рокитанским. Терапевтический архив. 2021;93(12):1564–1568. DOI: 10.26442/00403660.2021.12.201219
________________________________________________
Knyazev OV, Kagramanova AV, Parfenov AI. Ulcerative colitis. To the 180th anniversary of the description by Karl Rokytansky. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(12):1564–1568.
DOI: 10.26442/00403660.2021.12.201219
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье названы основные исторические вехи в описании и изучении язвенного колита со времен Гиппократа и до наших дней.
Первое описание морфологической картины неспецифического язвенного колита (НЯК) представлено венским патологоанатомом Карлом Рокитанским в 1842 г. Термин «язвенный колит» предложил С. Уилкс (S. Wilks) в 1859 г. Подробное описание заболевания в 1875 г. продемонстрировали Уилкс и Моксон (S. Wilks, W. Moxon). В самостоятельную нозологическую форму НЯК выделен в 1888 г. английским врачом Уайтом (W. White). Боас (Boas) в 1903 г. впервые представил дифференциальную диагностику НЯК и хронической дизентерии. Термин «неспецифический язвенный колит» в России впервые введен А.С. Казаченко в докладе на XIII Съезде российских хирургов в 1913 г.
Ключевые слова: воспалительные заболевания кишечника, история описания, язвенный колит
Первое описание морфологической картины неспецифического язвенного колита (НЯК) представлено венским патологоанатомом Карлом Рокитанским в 1842 г. Термин «язвенный колит» предложил С. Уилкс (S. Wilks) в 1859 г. Подробное описание заболевания в 1875 г. продемонстрировали Уилкс и Моксон (S. Wilks, W. Moxon). В самостоятельную нозологическую форму НЯК выделен в 1888 г. английским врачом Уайтом (W. White). Боас (Boas) в 1903 г. впервые представил дифференциальную диагностику НЯК и хронической дизентерии. Термин «неспецифический язвенный колит» в России впервые введен А.С. Казаченко в докладе на XIII Съезде российских хирургов в 1913 г.
Ключевые слова: воспалительные заболевания кишечника, история описания, язвенный колит
________________________________________________
The article describes the main historical milestones in the description and study of ulcerative colitis from the time of Hippocrates to the present day. The first description of the morphological picture of non-specific ulcerative colitis (NUC) was presented by the Viennese pathologist Karl Rokitansky in 1842. The term "ulcerative colitis" was coined by S. Wilks in 1859. A detailed description of the disease was presented in 1875 by S. Wilks and W. Maxon. In an independent nosological form, NUC was isolated in 1888 by the English doctor White. Boas in 1903. For the first time, he presented the differential diagnosis of NUC and chronic dysentery. The term "non-specific ulcerative colitis" in Russia was first introduced by A.S. Kazachenko in a report at the XIII Congress of Russian Surgeons in 1913.
Keywords: inflammatory bowel disease, description history, ulcerative colitis
Полный текст
Список литературы
1. Хатьков И.Е., Парфенов А.И., Князев О.В., и др. Воспалительные заболевания кишечника в практике терапевта и хирурга. М.: Вита-ПРЕСС, 2017 [Khatkov IE, Parfenov AI, Kniazev OV, et al. Vospalitel'nye zabolevaniia kishechnika v praktike terapevta i khirurga. Moscow: Vita-PRESS, 2017 (in Russian)].
2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54.
DOI:10.1053/j.gastro.2011.10.001
3. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713-25.
4. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2010;6(5):339-46. DOI:10.1056/NEJMc1113995
5. Roberts CJ, Diggle R. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed). 1982;285(6339):440. DOI:10.1136/bmj.284.6317.706
6. Rutgeerts P, D’Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology. 1994;106(5):1251-3.
DOI:10.1016/0016-5085(94)90016-7
7. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology. 2003;124(2):521-36. DOI:10.1053/gast.2003.50045
8. Kirsner JB. Ulcerative colitis. In: JB Kirsner. Origin and directions of inflammatory bowel disease. Dordrecht: Kluwer Academic, 2001.
9. Alexander-Williams J. Historical review. In: Inflammatory bowel diseases. 3rd ed. Ed RB Alan, JM Rhodes, SB Hanauer, et al. Edinburgh: Churchill Livingstone, 1983; p. 3-10.
10. Lim ML, Wallace MR. Infectious diarrhea in history. Infect Dis Clin North Am. 2004;18(2):261-74. DOI:0.31631/2073-3046-2021-20-3-118-128
11. Aretaeus of Cappadocia. The extant works of Aretaeus, the Cappadocian. Ed, transl. F. Adams (1856). Republished Boston: Milford House, 1972.
12. Sydenham T. The whole works of that excellent practical physician, Dr Thomas Sydenham, the third edition corrected from original Latin by John Pechey. London: Wellington, 1701.
13. Wilson PJE. The young pretender. Br Med J. 1961;2:1226.
14. Burch W, Gump DW, Krawitt EL. Historical case report of Sir William Johnson, the Mohawk Baronet. Am J Gastroenterol. 1992;87(8):1023-5.
15. Baillie M. The morbid anatomy of some of the most important parts of the human body. London: J. Johnson and G. Nicol, 1793.
16. Morgagni GB. De sedibu et causis morborum, remondini. Venice, 1761.
17. Rokitansky K. A manual of pathologic anatomy. 4 Volumes. London: Sydenham Society, p. 1849-54.
18. Crohn BB. An historic note on ulcerative colitis. Gastroenterology. 1962;42:366-7.
19. Wilks S. Morbid appearances in the intestine of Miss Bankes. London Medical Gazette. 1859;2:264-5.
20. Allchin WH. A discussion on “ulcerative colitis”: introductory address. Proc R Soc Med. 1909;2 (Med Sect):59-75.
21. Kirsner JB. The development of American gastroenterology. New York: Raven Press, 1990.
22. Mulder DJ, Noble AJ, Justinich CJ, Duffin JM. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis. 2014;8(5):341-8 DOI:10.1016/j.crohns.2013.09.009
23. Robson MAW. Cases of colitis with ulceration treated by inguinal colostomy and local treatment of the ulcerated surfaces with subsequent closure of the artificial anus. Trans Clin Soc Lond. 1893;26:213-5.
24. Weir RF. A new use for the useless appendix in the surgical treatment of obstinate colitis. Med Rec (NY). 1902;62:201-2.
25. Bassler A. Ulcerative colitis. Interstate Med J. 1913;20:705-6.
26. Helmholz HF Chronic ulcerative colitis in childhood. Am J Dis Child. 1923;26(5):418-30.
27. Jackman RJ, Bargen JA, Helmholz HF. Life histories of ninety-five children with chronic ulcerative colitis: a statistical study based on comparison with a whole group of eight hundred and seventy-one patients. Am J Dis Child. 1940;59(3):459-67.
28. Davidson M. Infantilism in ulcerative colitis. Arch Intern Med (Chic). 1939;64(6):1187-95.
29. Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133-44.
30. Hewitt JH, Howard WT. Chronic ulcerative colitis with polyps: a consideration of the so-called colitis polyposa (Virchow). Arch Intern Med (Chic). 1915;15(5_1):714-23.
31. Wangensteen OH, Toon RW. Primary resection of the colon and rectum with particular reference to cancer and ulcerative colitis. Am J Surg. 1948;75(2):384-404.
32. Gill AM. Treatment of ulcerative colitis with intestinal mucosa. Proc R Soc Med. 1946;39:517-9.
33. Burnford J. Ulcerative colitis: its treatment by ionization: summary of twenty-eight cases. Br Med J. 1930;2(3641):640-1.
34. Strauss H. Ueber Kolitis-Probleme. Dtsch Med Wochenschr. 1923;49(52):1568-70.
35. Murray C. Psychogenic factors in the etiology of ulcerative colitis. Am J Dig Dis. 1930;180:239.
36. Sullivan A. Psychogenic factors and ulcerative colitis. Am J Dig Dis. 1935;2:651.
37. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol. 2001;7(2):175-84. DOI:10.3748/wjg.v7.i2.175
38. Braegger CP, Nicholls S, Murch SH, et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet.
1992;339:89-91. DOI:10.1016/0140-6736(92)90999-j
39. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemis – try in chronic inflammatory bowel disease. Gut. 1993;34:1705-9.
DOI:10.1136/gut.34.12.1705
40. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991;32:913-7. DOI:10.1136/gut.32.8.913
41. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-76. DOI:10.1056/NEJMoa050516
42. Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369(8):699-710. DOI:10.1056/NEJMoa1215734
43. Sands BE, Sandborn WJ, Panaccione R, et al.; UNIFI Study Group. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2019;381(13):1201-14.
DOI:10.1056/nejmoa1900750
44. Князев О.В., Парфенов А.И. Клеточные технологии и биологическая терапия хронических воспалительных заболеваний кишечника. М.: Вита-ПРЕСС, 2020 [Kniazev OV, Parfenov AI. Kletochnye tekhnologii i biologicheskaia terapiia khronicheskikh vospalitelnykh zabolevanii kishechnika. Moscow: Vita-PRESS, 2020 (in Russian)].
2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54.
DOI:10.1053/j.gastro.2011.10.001
3. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713-25.
4. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2010;6(5):339-46. DOI:10.1056/NEJMc1113995
5. Roberts CJ, Diggle R. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed). 1982;285(6339):440. DOI:10.1136/bmj.284.6317.706
6. Rutgeerts P, D’Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology. 1994;106(5):1251-3.
DOI:10.1016/0016-5085(94)90016-7
7. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology. 2003;124(2):521-36. DOI:10.1053/gast.2003.50045
8. Kirsner JB. Ulcerative colitis. In: JB Kirsner. Origin and directions of inflammatory bowel disease. Dordrecht: Kluwer Academic, 2001.
9. Alexander-Williams J. Historical review. In: Inflammatory bowel diseases. 3rd ed. Ed RB Alan, JM Rhodes, SB Hanauer, et al. Edinburgh: Churchill Livingstone, 1983; p. 3-10.
10. Lim ML, Wallace MR. Infectious diarrhea in history. Infect Dis Clin North Am. 2004;18(2):261-74. DOI:0.31631/2073-3046-2021-20-3-118-128
11. Aretaeus of Cappadocia. The extant works of Aretaeus, the Cappadocian. Ed, transl. F. Adams (1856). Republished Boston: Milford House, 1972.
12. Sydenham T. The whole works of that excellent practical physician, Dr Thomas Sydenham, the third edition corrected from original Latin by John Pechey. London: Wellington, 1701.
13. Wilson PJE. The young pretender. Br Med J. 1961;2:1226.
14. Burch W, Gump DW, Krawitt EL. Historical case report of Sir William Johnson, the Mohawk Baronet. Am J Gastroenterol. 1992;87(8):1023-5.
15. Baillie M. The morbid anatomy of some of the most important parts of the human body. London: J. Johnson and G. Nicol, 1793.
16. Morgagni GB. De sedibu et causis morborum, remondini. Venice, 1761.
17. Rokitansky K. A manual of pathologic anatomy. 4 Volumes. London: Sydenham Society, p. 1849-54.
18. Crohn BB. An historic note on ulcerative colitis. Gastroenterology. 1962;42:366-7.
19. Wilks S. Morbid appearances in the intestine of Miss Bankes. London Medical Gazette. 1859;2:264-5.
20. Allchin WH. A discussion on “ulcerative colitis”: introductory address. Proc R Soc Med. 1909;2 (Med Sect):59-75.
21. Kirsner JB. The development of American gastroenterology. New York: Raven Press, 1990.
22. Mulder DJ, Noble AJ, Justinich CJ, Duffin JM. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis. 2014;8(5):341-8 DOI:10.1016/j.crohns.2013.09.009
23. Robson MAW. Cases of colitis with ulceration treated by inguinal colostomy and local treatment of the ulcerated surfaces with subsequent closure of the artificial anus. Trans Clin Soc Lond. 1893;26:213-5.
24. Weir RF. A new use for the useless appendix in the surgical treatment of obstinate colitis. Med Rec (NY). 1902;62:201-2.
25. Bassler A. Ulcerative colitis. Interstate Med J. 1913;20:705-6.
26. Helmholz HF Chronic ulcerative colitis in childhood. Am J Dis Child. 1923;26(5):418-30.
27. Jackman RJ, Bargen JA, Helmholz HF. Life histories of ninety-five children with chronic ulcerative colitis: a statistical study based on comparison with a whole group of eight hundred and seventy-one patients. Am J Dis Child. 1940;59(3):459-67.
28. Davidson M. Infantilism in ulcerative colitis. Arch Intern Med (Chic). 1939;64(6):1187-95.
29. Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133-44.
30. Hewitt JH, Howard WT. Chronic ulcerative colitis with polyps: a consideration of the so-called colitis polyposa (Virchow). Arch Intern Med (Chic). 1915;15(5_1):714-23.
31. Wangensteen OH, Toon RW. Primary resection of the colon and rectum with particular reference to cancer and ulcerative colitis. Am J Surg. 1948;75(2):384-404.
32. Gill AM. Treatment of ulcerative colitis with intestinal mucosa. Proc R Soc Med. 1946;39:517-9.
33. Burnford J. Ulcerative colitis: its treatment by ionization: summary of twenty-eight cases. Br Med J. 1930;2(3641):640-1.
34. Strauss H. Ueber Kolitis-Probleme. Dtsch Med Wochenschr. 1923;49(52):1568-70.
35. Murray C. Psychogenic factors in the etiology of ulcerative colitis. Am J Dig Dis. 1930;180:239.
36. Sullivan A. Psychogenic factors and ulcerative colitis. Am J Dig Dis. 1935;2:651.
37. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol. 2001;7(2):175-84. DOI:10.3748/wjg.v7.i2.175
38. Braegger CP, Nicholls S, Murch SH, et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet.
1992;339:89-91. DOI:10.1016/0140-6736(92)90999-j
39. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemis – try in chronic inflammatory bowel disease. Gut. 1993;34:1705-9.
DOI:10.1136/gut.34.12.1705
40. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991;32:913-7. DOI:10.1136/gut.32.8.913
41. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-76. DOI:10.1056/NEJMoa050516
42. Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369(8):699-710. DOI:10.1056/NEJMoa1215734
43. Sands BE, Sandborn WJ, Panaccione R, et al.; UNIFI Study Group. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2019;381(13):1201-14.
DOI:10.1056/nejmoa1900750
44. Князев О.В., Парфенов А.И. Клеточные технологии и биологическая терапия хронических воспалительных заболеваний кишечника. М.: Вита-ПРЕСС, 2020 [Kniazev OV, Parfenov AI. Kletochnye tekhnologii i biologicheskaia terapiia khronicheskikh vospalitelnykh zabolevanii kishechnika. Moscow: Vita-PRESS, 2020 (in Russian)].
________________________________________________
1. Khatkov IE, Parfenov AI, Kniazev OV, et al. Vospalitel'nye zabolevaniia kishechnika v praktike terapevta i khirurga. Moscow: Vita-PRESS, 2017 (in Russian).
2. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54.
DOI:10.1053/j.gastro.2011.10.001
3. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365(18):1713-25.
4. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol. 2010;6(5):339-46. DOI:10.1056/NEJMc1113995
5. Roberts CJ, Diggle R. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed). 1982;285(6339):440. DOI:10.1136/bmj.284.6317.706
6. Rutgeerts P, D’Haens G, Hiele M, et al. Appendectomy protects against ulcerative colitis. Gastroenterology. 1994;106(5):1251-3.
DOI:10.1016/0016-5085(94)90016-7
7. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology. 2003;124(2):521-36. DOI:10.1053/gast.2003.50045
8. Kirsner JB. Ulcerative colitis. In: JB Kirsner. Origin and directions of inflammatory bowel disease. Dordrecht: Kluwer Academic, 2001.
9. Alexander-Williams J. Historical review. In: Inflammatory bowel diseases. 3rd ed. Ed RB Alan, JM Rhodes, SB Hanauer, et al. Edinburgh: Churchill Livingstone, 1983; p. 3-10.
10. Lim ML, Wallace MR. Infectious diarrhea in history. Infect Dis Clin North Am. 2004;18(2):261-74. DOI:0.31631/2073-3046-2021-20-3-118-128
11. Aretaeus of Cappadocia. The extant works of Aretaeus, the Cappadocian. Ed, transl. F. Adams (1856). Republished Boston: Milford House, 1972.
12. Sydenham T. The whole works of that excellent practical physician, Dr Thomas Sydenham, the third edition corrected from original Latin by John Pechey. London: Wellington, 1701.
13. Wilson PJE. The young pretender. Br Med J. 1961;2:1226.
14. Burch W, Gump DW, Krawitt EL. Historical case report of Sir William Johnson, the Mohawk Baronet. Am J Gastroenterol. 1992;87(8):1023-5.
15. Baillie M. The morbid anatomy of some of the most important parts of the human body. London: J. Johnson and G. Nicol, 1793.
16. Morgagni GB. De sedibu et causis morborum, remondini. Venice, 1761.
17. Rokitansky K. A manual of pathologic anatomy. 4 Volumes. London: Sydenham Society, p. 1849-54.
18. Crohn BB. An historic note on ulcerative colitis. Gastroenterology. 1962;42:366-7.
19. Wilks S. Morbid appearances in the intestine of Miss Bankes. London Medical Gazette. 1859;2:264-5.
20. Allchin WH. A discussion on “ulcerative colitis”: introductory address. Proc R Soc Med. 1909;2 (Med Sect):59-75.
21. Kirsner JB. The development of American gastroenterology. New York: Raven Press, 1990.
22. Mulder DJ, Noble AJ, Justinich CJ, Duffin JM. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis. 2014;8(5):341-8 DOI:10.1016/j.crohns.2013.09.009
23. Robson MAW. Cases of colitis with ulceration treated by inguinal colostomy and local treatment of the ulcerated surfaces with subsequent closure of the artificial anus. Trans Clin Soc Lond. 1893;26:213-5.
24. Weir RF. A new use for the useless appendix in the surgical treatment of obstinate colitis. Med Rec (NY). 1902;62:201-2.
25. Bassler A. Ulcerative colitis. Interstate Med J. 1913;20:705-6.
26. Helmholz HF Chronic ulcerative colitis in childhood. Am J Dis Child. 1923;26(5):418-30.
27. Jackman RJ, Bargen JA, Helmholz HF. Life histories of ninety-five children with chronic ulcerative colitis: a statistical study based on comparison with a whole group of eight hundred and seventy-one patients. Am J Dis Child. 1940;59(3):459-67.
28. Davidson M. Infantilism in ulcerative colitis. Arch Intern Med (Chic). 1939;64(6):1187-95.
29. Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann Intern Med. 1963;59:133-44.
30. Hewitt JH, Howard WT. Chronic ulcerative colitis with polyps: a consideration of the so-called colitis polyposa (Virchow). Arch Intern Med (Chic). 1915;15(5_1):714-23.
31. Wangensteen OH, Toon RW. Primary resection of the colon and rectum with particular reference to cancer and ulcerative colitis. Am J Surg. 1948;75(2):384-404.
32. Gill AM. Treatment of ulcerative colitis with intestinal mucosa. Proc R Soc Med. 1946;39:517-9.
33. Burnford J. Ulcerative colitis: its treatment by ionization: summary of twenty-eight cases. Br Med J. 1930;2(3641):640-1.
34. Strauss H. Ueber Kolitis-Probleme. Dtsch Med Wochenschr. 1923;49(52):1568-70.
35. Murray C. Psychogenic factors in the etiology of ulcerative colitis. Am J Dig Dis. 1930;180:239.
36. Sullivan A. Psychogenic factors and ulcerative colitis. Am J Dig Dis. 1935;2:651.
37. Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol. 2001;7(2):175-84. DOI:10.3748/wjg.v7.i2.175
38. Braegger CP, Nicholls S, Murch SH, et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet.
1992;339:89-91. DOI:10.1016/0140-6736(92)90999-j
39. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT. Location of tumour necrosis factor alpha by immunohistochemis – try in chronic inflammatory bowel disease. Gut. 1993;34:1705-9.
DOI:10.1136/gut.34.12.1705
40. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991;32:913-7. DOI:10.1136/gut.32.8.913
41. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-76. DOI:10.1056/NEJMoa050516
42. Feagan BG, Rutgeerts P, Sands BE, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369(8):699-710. DOI:10.1056/NEJMoa1215734
43. Sands BE, Sandborn WJ, Panaccione R, et al.; UNIFI Study Group. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2019;381(13):1201-14.
DOI:10.1056/nejmoa1900750
44. Kniazev OV, Parfenov AI. Kletochnye tekhnologii i biologicheskaia terapiia khronicheskikh vospalitelnykh zabolevanii kishechnika. Moscow: Vita-PRESS, 2020 (in Russian).
Авторы
О.В. Князев1–3, А.В. Каграманова1, А.И. Парфенов*1
1 ГБУЗ «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения г. Москвы, Москва, Россия;
2 ФГБУ «Национальный медицинский исследовательский центр колопроктологии им. А.Н. Рыжих» Минздрава России, Москва, Россия;
3 ГБУ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента» Департамента здравоохранения г. Москвы, Москва, Россия
*asfold@mail.ru
1 ГБУЗ «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения г. Москвы, Москва, Россия;
2 ФГБУ «Национальный медицинский исследовательский центр колопроктологии им. А.Н. Рыжих» Минздрава России, Москва, Россия;
3 ГБУ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента» Департамента здравоохранения г. Москвы, Москва, Россия
*asfold@mail.ru
________________________________________________
Oleg V. Knyazev1–3, Anna V. Kagramanova1, Asfold I. Parfenov*1
1 Loginov Moscow Clinical Scientific Center, Moscow, Russia;
2 Ryzhykh National Medical Research Сenter of Coloproctology, Moscow, Russia;
3 Research Institute of Health Organization and Medical Management, Moscow, Russia
*asfold@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.